Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schroeter AL, Diaz Perez JL, Winkelmann RK (1975) Livedo vasculitis (the vasculitis of atrophie blanche): immunohistopathologic study. Arch Dermatol 111:188–193
Marzano AV, Vanotti M, Alessi E (2003) Widespread livedoid vasculopathy. Acta Derm Venereol 83:457–460
Bard JW, Winkelmann RK (1967) Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol 96:489–499
Mimouni D, Ng PP, Rencic A et al (2003) Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 148:789–794
Maessen-Visch MB, Koedam MI, Hamulyák K, Neumann HA (1999) Atrophie blanche. Int J Dermatol 38:161–172
Hairston BR, Davis MD, Pittelkow MR, Ahmed I (2006) Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 142:1413–1418
Biedermann T, Flaig MJ, Sander CA (2000) Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol 27:410–412
Calamia KT, Balabanova M, Perniciaro C, Walsh JS (2002) Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol 46:133–137
Anavekar NS, Kelly R (2007) Heterozygous prothrombin gene mutation associated with livedoid vasculopathy. Australas J Dermatol 48:120–123
Gibson GE, Li H, Pittelkow MR (1999) Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol 40:279–281
Cardoso R, Goncalo M, Tellechea O et al (2007) Livedoid vasculopathy and hypercoagulability in a patient with primary Sjogren’s syndrome. Int J Dermatol 46:431–434
Deng A, Gocke CD, Hess J et al (2006) Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 142:1466–1469
Boyvat A, Kundakçi N, Babikir MO, Gürgey E (2000) Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 143:840–842
Meiss F, Marsch WC, Fischer M (2006) Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol 16:159–162
Acland KM, Darvay A, Wakelin SH, Russell-Jones R (1999) Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 140:131–135
Grasland A, Crickx B, Blanc M, Pouchot J, Vinceneux P (2000) Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies. Ann Med Interne (Paris) 151:408–410
Papi M, Didona B, De Pita O et al (1998) Livedo vasculopathy vs. small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol 134:447–452
Browning CE, Callen JP (2006) Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 142:75–78
Lewerenz V, Burchardt T, Büchau A, Ruzicka T, Megahed M (2004) Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome. Hautarzt 55:379–381
Hairston BR, Davis MD, Gibson LE, Drage LA (2003) Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 139:987–990
Klein KL, Pittelkow MR (1992) Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 67:923–933
Pitarch G, Rodriguez-Serna M, Torrijos A, Oliver V, Fortea JM (2005) Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins. Acta Derm Venereol 85:374–375